BioCryst Pharmaceuticals has received a contract valued at up to $69m from the US Department of Health and Human Services ...
GlobalData’s report assesses the drugs in the Insulin Like Growth Factor I pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Metabotropic Glutamate Receptor 7 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Bromodomain Testis Specific Protein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development ...
GlobalData’s report assesses the drugs in the Cathepsin L1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Cell Division Cycle 7 Related Protein Kinase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the ...
GlobalData’s report assesses the drugs in the Integrin Beta 7 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the High Mobility Group Protein B1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Collagenase 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Plasma Kallikrein  pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
GlobalData’s report assesses the drugs in the Cholesteryl Ester Transfer Protein pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline ...
GlobalData’s report assesses the drugs in the Islet Amyloid Polypeptide pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.